Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-828 (S-Amlodipine/Telmisartan) in Stage 2 Hypertension
NCT01634295Phase 3Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jul 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telmisartan in hypertension (HTN), sponsored by Chong Kun Dang Holdings. Started Jul 2012; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01634295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01634295.